Nordion boosts revenue as AECL reactor back on line

Guest Contributor
December 22, 2011

Revenues at Nordion Inc have bounced back with the return to service of the nuclear reactor that supplies the Ottawa-based company with the raw materials for its medical isotopes. Overall revenue jumped 23% to $274 million in 2011, up from $222 million in 2010 — the year the National Universal Reactor was shut down at Atomic Energy of Canada Ltd's Chalk River facility. Revenue from medical isotopes increased 282% from $9.4 million to $36.1 million, boosting net income from continuing operations to $43.5 million, compared to a loss of $83.8 million in 2010. Nordion is one of the world's largest suppliers of medical isotopes derived from Molybdenum-99, which is generated by AECL through a long-standing agreement with the Crown corporation….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.